| CLDX Stock | | | USD 27.44 0.45 1.61% |
Celldex Therapeutics financial indicator trend analysis is way more than just evaluating Celldex Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Celldex Therapeutics is a good investment. Please check the relationship between Celldex Therapeutics Other Operating Expenses and its Depreciation And Amortization accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Celldex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in unemployment.
For more information on how to buy Celldex Stock please use our
How to Invest in Celldex Therapeutics guide.
Other Operating Expenses vs Depreciation And Amortization
Other Operating Expenses vs Depreciation And Amortization Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Celldex Therapeutics Other Operating Expenses account and
Depreciation And Amortization. At this time, the significance of the direction appears to have weak relationship.
The correlation between Celldex Therapeutics' Other Operating Expenses and Depreciation And Amortization is 0.32. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Celldex Therapeutics, assuming nothing else is changed. The correlation between historical values of Celldex Therapeutics' Other Operating Expenses and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Celldex Therapeutics are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Other Operating Expenses i.e., Celldex Therapeutics' Other Operating Expenses and Depreciation And Amortization go up and down completely randomly.
Correlation Coefficient | 0.32 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Celldex Therapeutics. It is also known as Celldex Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.
Most indicators from Celldex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Celldex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Celldex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in unemployment.
For more information on how to buy Celldex Stock please use our
How to Invest in Celldex Therapeutics guide.At this time, Celldex Therapeutics'
Tax Provision is fairly stable compared to the past year.
Enterprise Value is likely to rise to about 1.8
B in 2024, whereas
Selling General Administrative is likely to drop slightly above 29.4
M in 2024.
Celldex Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Celldex Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Celldex Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Celldex Stock Analysis
When running Celldex Therapeutics' price analysis, check to
measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.